Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Smith & Nephew Snats (SNN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,985,507
  • Shares Outstanding, K 437,360
  • Annual Sales, $ 4,765 M
  • Annual Income, $ 767,000 K
  • 36-Month Beta 0.58
  • Price/Sales 3.35
  • Price/Cash Flow 12.56
  • Price/Book 3.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.00
  • Number of Estimates 1
  • High Estimate 0.00
  • Low Estimate 0.00
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.22 +13.83%
on 10/29/18
37.56 -2.37%
on 11/07/18
+2.14 (+6.20%)
since 10/16/18
3-Month
32.22 +13.83%
on 10/29/18
37.61 -2.50%
on 10/01/18
+1.33 (+3.76%)
since 08/16/18
52-Week
32.22 +13.83%
on 10/29/18
39.85 -7.98%
on 04/23/18
+0.70 (+1.95%)
since 11/16/17

Most Recent Stories

More News
Smith & Nephew Presents Excellent Results for JOURNEY(TM) II Total Knee at the 2018 American Association of Hip and Knee Surgeons

Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, presented a number of compelling clinical outcomes around its flagship JOURNEY II BCS knee earlier this month at the American...

SNN : 36.67 (+0.33%)
Surgical Instruments Market 2018 Report Covers the Market Landscape and its Growth Prospects Over the Coming Years: Radiant Insights, Inc.

The Global Surgical Instruments Market estimated to develop at a substantial CAGR of 6.22% during the period 2018-2022. The surgical instruments are extensively utilized in surgical procedure for creation...

SNN : 36.67 (+0.33%)
MDT : 93.70 (+1.00%)
CNMD : 68.58 (-0.36%)
Orthopedic Plates & Screws - Global Market Analysis & Outlook to 2024 Featuring Profiles for Zimmer Biomet, DePuy Synthes, Wright Tornier, Smith & Nephew, Stryker, Exactech, Integra and Medtronic - ResearchAndMarkets.com

The "Orthopedic Plates and Screws Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

SNN : 36.67 (+0.33%)
MDT : 93.70 (+1.00%)
Wound Dressings Market Report 2018 Provides a Clear Insight Into the Market Share Analysis of Key Industry Players: Radiant Insights, Inc.

The global Wound Dressings Market is anticipated to rise at a staggering CAGR of 5.4% by 2022. Wound dressing and wound healing are complementary to each other and it is a constantly evolving field, as...

SNN : 36.67 (+0.33%)
Data Projects the Global Medical Device Industry is Set to Grow

Data provided by Lucintel projects that the future of the global medical device industry will provide opportunities in public and private hospitals. The sector is expected to reach an estimated USD 409.5...

SNN : 36.67 (+0.33%)
MD : 39.28 (-1.48%)
SCYX : 0.81 (-3.57%)
OMI : 8.59 (-3.05%)
PCTL : 0.1550 (-38.00%)
Two new studies demonstrate INTERTAN(TM) Intertrochanteric Antegrade Nail improves patient outcomes and lowers healthcare costs when treating hip fractures

Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announced at the Orthopaedic Trauma Association Annual Meeting in Orlando, FL USA two new studies showing positive clinical...

SNN : 36.67 (+0.33%)
North American Arthroscopy Devices Market Outlook to 2025 featuring Smith & Nephew, Stryker, DePuy Synthes and More - ResearchAndMarkets.com

The "North America Arthroscopy Devices Market Outlook to 2025" report has been added to ResearchAndMarkets.com's offering.

SNN : 36.67 (+0.33%)
Wound care market is expected to be an US$ 30 Billion opportunity by 2024

Wound Care Market, Global Forecast by Products (Traditional Adhesive Dressings, Traditional Gauze Dressings, Non-Adherent Dressings, Film Dressings, Foam Dressings, Hydrogel, Hydrocolloid, Alginate Dressings,...

SNN : 36.67 (+0.33%)
CNVVY : 8.4800 (+2.29%)
Opportunity Outlook on the Global Medical Videoscopes Market (2018-2024): Featuring Olympus, Stryker, Karl Storz, Fujifilm, Hoya, Smith & Nephew, and more - ResearchAndMarkets.com

The "Medical Videoscopes Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

SNN : 36.67 (+0.33%)
Conformis Announces Settlement of Patent Dispute with Smith & Nephew

Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that fit each...

SNN : 36.67 (+0.33%)
CFMS : 0.51 (-3.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade SNN with:

Business Summary

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative...

See More

Key Turning Points

2nd Resistance Point 36.96
1st Resistance Point 36.81
Last Price 36.67
1st Support Level 36.41
2nd Support Level 36.15

See More

52-Week High 39.85
Fibonacci 61.8% 36.93
Last Price 36.67
Fibonacci 50% 36.03
Fibonacci 38.2% 35.13
52-Week Low 32.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar